NEW YORK (360Dx) – A group of international researchers is developing a new test that could be used to guide prostate cancer treatment selection, particularly among advanced cases.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.
Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.
Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.
In Science this week: three studies from the Ruminant Genome Project, and more.
This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.
This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).
This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.